Molecular underpinnings of RB status as a biomarker of poor outcome in advanced prostate cancer.

189Background: There is emergent and compelling evidence to support RB status as a biomarker in advanced prostate cancer. RB loss is strongly associated with poor progression-free, disease-specific...